Русский
Self-sampling of biological material at the first stage of screening for HPV-associated diseases in HIV-infected women in the Moscow region
DOI: https://dx.doi.org/10.18565/epidem.2023.13.3.81-7
Popova A.A., Vinogradova N.A., Romanyuk T.N., Domonova E.A.
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia
Materials and methods. The study involved 100 HIV-infected women. The results of testing of samples of vaginal mucosa, taken by the patient herself, and scraping of the cervical canal, taken by a gynecologist, were analyzed. The ease of use of the set of consumables was assessed using a questionnaire. Real-time PCR was used to determine HPV DNA. Cytological examination was performed using the technique of liquid cytology with Papanicolaou staining of cervical micropreparations.
Results. The frequency of detection of 13 high-risk oncogenic HPV types in samples of vaginal discharge and scraping of epithelial cells from the mucous membrane of the cervical canal was 42 and 30% (p > 0.05). According to the results of the survey (assessment was carried out on a 10-point scale, where difficult/very uncomfortable = 0, easy/very comfortable = 10), the ease of taking biological material was rated by study participants at an average of 9.4 points, the availability of understanding and ease of following the instructions – at 9.5 points, comfort of using the set – 8.9 points. An assessment of personal preferences in choosing a method for taking a biomaterial showed that only 15% of respondents would prefer a traditional visit to a gynecologist in the future.
Conclusion. There was no significant difference between the compared methods of taking biological material at the first stage of screening for cervical and vaginal precancerous diseases (p > 0.05). The use of an individual set of consumables for HPV testing will significantly increase the coverage of the population of HIV-infected women, as well as identify a risk group among them.
Literature
1. Cancers Associated with Human Papillomavirus (HPV). Last reviewed: October 3, 2022. https://www.cdc.gov/cancer/hpv/basic_info/cancers.htm 2. Предупреждение развития заболеваний папилломавирусной этиологии у ВИЧ-инфицированных лиц: Методические рекомендации МР 3.1.5.0298-22. Бюллетень нормативных и методических документов Госсанэпиднадзора 2022: (4): 34–46. (Prevention of the development of diseases of papillomavirus etiology in HIV-infected persons: Guidelines MP 3.1.5.0298-22). Bulletin of regulatory and methodological documents of the State Sanitary and Epidemiological Supervision 2022: (4): 34–46. (In Russ.). 3. Клинические рекомендации – Цервикальная интраэпителиальная неоплазия, эрозия и эктропион шейки матки – 2020-2021-2022 (31.05.2021). (In Russ.). https://cr.minzdrav.gov.ru/recomend/597_1 (Clinical guidelines – Cervical intraepithelial neoplasia, erosion and ectropion of the cervix – 2020-2021-2022 (31.05.2021)). (In Russ.). https://cr.minzdrav.gov.ru/recomend/597_1 4 Каприн А.Д., Старинский В.В., Шахзадова А.О. (ред.). Злокачественные новообразования в России в 2021 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022. 252 с. https://oncology-association.ru/wp-content/uploads/2022/11/zlokachestvennye-novoobrazovaniya-v-rossii-v-2021-g_zabolevaemost-i-smertnost.pdf Kaprin A.D., Starinsky V.V., Shahzadova A.O. (eds.). (Malignant neoplasms in Russia in 2021 (morbidity and mortality)). Moscow, 2022. 252 p. ISBN 978-5-85502-280- 3 (In Russ.). https://oncology-association.ru/wp-content/uploads/2022/11/zlokachestvennye-novoobrazovaniya-v-rossii-v-2021-g_zabolevaemost-i-smertnost.pdf 5. ВИЧ в России на 31.12.2021 г. http://www.hivrussia.info/wp-content/uploads/2022/03/Spravka-VICH-v-Rossii-na-31.12.2021-g..pdf HIV in Russia as of December 31, 2021. (In Russ.). http://www.hivrussia.info/wp-content/uploads/2022/03/Spravka-VICH-v-Rossii-na-31.12.2021-g..pdf 6. Попова А.А., Домонова Э.А., Виноградова Н.А., Шипулина О.Ю. Аногенитальная папилломавирусная инфекция у ВИЧ-инфицированных женщин (по результатам пилотного исследования в Московском регионе) Эпидемиол. инфекц. болезни. Актуал. вопр. 2021; 11(3): 40–5. DOI: 10.18565/epidem.2021.11.3.40-5 Popova A.A., Domonova E.A., Vinogradova N.A., Shipulina O.Yu. (Anogenital human papillomavirus infection in HIV-infected women (according to the results of a pilot study in the Moscow Region)). Epidemiоlоgy and infectious diseases. Сurrent items 2021; 11(3): 40–5. (In Russ.). DOI: 10.18565/epidem.2021.11.3.40-5 7. Попова А.А., Шипулина О.Ю., Лешкина Г.В., Дмитрюкова М.Ю., Стребкова Е.А., Покровская А.В. Информированность ВИЧ-инфицированных женщин о роли ВПЧ в развитии рака шейки матки в Москве и Самаре. Материалы V Межведомственной научно-практической конференции «Инфекционные болезни – актуальные проблемы, лечение и профилактика» (Москва, 16–17 мая 2019 г.). М., 2019: 63. Popova A.A., Shipulina O.Yu., Leshkina G.V., Dmitryukova M. Yu., Strebkova E.A., Pokrovskaya A.V. (Awareness of HIV-infected women about the role of HPV in the development of cervical cancer in Moscow and Samara. Materials of the V Interdepartmental Scientific and Practical Conference «Infectious Diseases - Actual Problems, Treatment and Prevention»). (Moscow, May 16–17, 2019). M., 2019: 63. (In Russ.). 8. Роговская С.И., Шабалова И.П., Улумбекова Г.Э, Короленкова Л.И., Бебнева Т.Н., Гущин А.Е. и др. Организационные вопросы профилактики рака шейки матки в России. ОРГЗДРАВ: новости, мнения, обучение. Вестник ВШОУЗ 2021; 7(4): 16–31. DOI:10.33029/2411-8621-2021-7-4-16-31 Rogovskaya S.I., Shabalova I.P., Ulumbekova G.E., Korolenkova L.I., Bebneva T.N., Gushchin A.E. et al. (Organizational issues of cervical cancer prevention in Russia. ORGZDRAV: news, opinions, training). Vestnik VSHOUZ 2021; 7(4): 16–31. (In Russ.). DOI:10.33029/2411-8621-2021-7-4-16-31 9. Попова А.А., Домонова Э.А., Головешкина Е.Н., Громова А.В., Махова Т.И., Петров А.С. и др. Скрининг возбудителей ИППП в уязвимых группах вне медицинских учреждений: самостоятельное взятие мазка из анального канала. Эпидемиол. инфекц. болезни. Актуал. вопр. 2022; 12(3): 46–53. DOI:10.18565/epidem.2022.12/3/46-53 Popova A.A., Domonova E.A., Goloveshkina E.N., Gromova A.V., Makhova T.I., Petrov A.S. (Screening for STI pathogens in vulnerable groups outside of healthcaare facilities: anal canal self-swabbing). Epidemiоlоgy and infectious diseases. Сurrent items 2022; 12(3): 46–53. (In Russ.). DOI:10.18565/epidem. 2022.12/3/46-53 10. Домонова Э.А., Творогова М.Г., Подколзин А.Т., Шипулина О.Ю., Карань Л.С., Яцышина С.Б. и др. Взятие, транспортировка, хранение биологического материала для ПЦР-диагностики: Методические рекомендации. М., 2021. 112 с. DOI: 10.36233/978-5-6045286-6-2 Domonova E.А., Tvorogova М.G., Podkolzin А.Т., Shipulina O.Yu., Karan L.S., Yatsyshina S.B. et al. (Collection, transportation, storage of biological material for PCR diagnostics. Methodological recommendations). Moscow, 2021. 112 p. (In Russ.). DOI: 10.36233/978-5-6045286-6-2 11. Wright T.C., Stoler M.Н, Behrens С.М., Sharma A., Zhang G., Wright T.L. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol. Oncol. 2015; 136(2): 189–97. 12. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. Last Updated: Aug. 18, 2021. Reviewed Jan. 11, 2023. https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/human-0?view=full 13. Liu G., Sharma M., Tan N., Barnabas R. HIV-positive women have higher risk of HPV infection, precancerous lesions, and cervical cancer: A systematic review and meta-analysis. AIDS 2018; 32(6): 795–808. doi: 10.1097/QAD. 0000000000001765 14. Kaoma M., Olayemi O., Mwaba M.H., Sikwewa K. Utilizing first void urine for high-risk HPV testing for cervical cancer screening in HIV-positive women in Katete, Zambia. BMC Women’s Health 2023; 23: 62–9. https://doi.org/10.1186/s12905-023-02212-7 15. Шипулина О.Ю., Попова А.А., Кравченко А.В., Деулина М.О., Дмитрюкова М.Ю., Романюк Т.Н. Распространение высокоонкогенных генотипов вируса папилломы человека у ВИЧ-позитивных и ВИЧ-негативных женщин. Инфекционные болезни 2016; 14(4): 26–30. DOI:10.20953/1729-9225-2016-4-26-30 Shipulina O.Yu., Popova A.A., Kravchenko A.V., Deulina M.O., Dmitryukova M.Yu., Romanyuk T.N. (Prevalence of high oncogenic risk genotypesof humanpapillomavirus in HIV-positive and HIV-negative females). Infectious Diseases 2016; 14(4): 26–30. (In Russ.). DOI:10.20953/1729-9225-2016-4-26-30
About the Autors
Anna A. Popova, Cand. Med. Sci., Senior Researcher, Central Research Institute of Epidemiology, Russian Federal Service for Surveillance of Consumer Rights Protection and Human Well-Being, Moscow, Russia; asya-med@mail.ru; https://orcid.org/0000-0001-9484-5917
Nadezhda А. Vinogradova, Junior Researcher, Central Research Institute of Epidemiology, Russian Federal Service for Surveillance of Consumer Rights Protection and Human Well-Being, Moscow, Russia; klimova@cmd.su; http://orcid.org/0000-0003-3288-0244
Tatyana N. Romanyuk, Biologist, Central Research Institute of Epidemiology, Russian Federal Service for Surveillance of Consumer Rights Protection and Human Well-Being, Moscow, Russia; tatiana.romaniuk@pcr.ms; https://orcid.org/0009-0006-1952-907X
Elvira A. Domonova, Cand. Boil. Sci., Head, Research Group for the Development of New Methods for Diagnosing Opportunistic аnd Papillomavirus Infections, Department of Molecular Diagnostics and Epidemiology, Central Research Institute of Epidemiology, Russian Federal Service for Surveillance of Consumer Rights Protection and Human Well-Being, Moscow, Russia; еlvira.domonova@pcr.ms; http://orcid.org/0000-0001-8262-3938
Similar Articles
